Operating Expenses Summary of Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation's latest annual operating expenses in 2023 was 126.72 Million TWD , down -7.03% from previous year.
Abnova (Taiwan) Corporation's latest quarterly operating expenses in 2024 Q1 was 30.34 Million TWD , down -13.23% from previous quarter.
Abnova (Taiwan) Corporation reported a annual operating expenses of 136.3 Million TWD in annual operating expenses 2022, down -10.51% from previous year.
Abnova (Taiwan) Corporation reported a annual operating expenses of 152.31 Million TWD in annual operating expenses 2021, up 0.23% from previous year.
Abnova (Taiwan) Corporation reported a quarterly operating expenses of 30.34 Million TWD for 2024 Q1, down -13.23% from previous quarter.
Abnova (Taiwan) Corporation reported a quarterly operating expenses of 33.08 Million TWD for 2023 Q3, up 1.07% from previous quarter.

Annual Operating Expenses Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Operating Expenses of Abnova (Taiwan) Corporation (2023 - 2009)

Year	Operating Expenses	Operating Expenses Growth
2023	126.72 Million TWD	-7.03%
2022	136.3 Million TWD	-10.51%
2021	152.31 Million TWD	0.23%
2020	151.96 Million TWD	-2.25%
2019	155.47 Million TWD	-5.05%
2018	163.75 Million TWD	-3.61%
2017	169.87 Million TWD	7.43%
2016	158.13 Million TWD	-2.76%
2015	162.63 Million TWD	0.84%
2014	161.27 Million TWD	2.78%
2013	156.92 Million TWD	-3.61%
2012	162.8 Million TWD	9.79%
2011	148.28 Million TWD	-0.93%
2010	149.67 Million TWD	8.81%
2009	137.55 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	27.5 Million TWD	4.08%
2024 Q1	30.34 Million TWD	-13.23%
2023 Q3	33.08 Million TWD	1.07%
2023 Q1	32.29 Million TWD	-5.31%
2023 FY	126.72 Million TWD	-7.03%
2023 Q2	32.73 Million TWD	1.37%
2023 Q4	34.97 Million TWD	5.71%
2022 FY	136.3 Million TWD	-10.51%
2022 Q2	34.53 Million TWD	5.7%
2022 Q3	34.98 Million TWD	1.29%
2022 Q4	34.1 Million TWD	-2.51%
2022 Q1	32.67 Million TWD	-9.89%
2021 Q2	39.25 Million TWD	1.23%
2021 Q1	38.78 Million TWD	2.02%
2021 Q4	36.26 Million TWD	-4.61%
2021 FY	152.31 Million TWD	0.23%
2021 Q3	38.01 Million TWD	-3.17%
2020 Q3	40.11 Million TWD	7.69%
2020 FY	151.96 Million TWD	-2.25%
2020 Q1	36.58 Million TWD	1.41%
2020 Q2	37.25 Million TWD	1.82%
2020 Q4	38.01 Million TWD	-5.24%
2019 Q3	38.51 Million TWD	0.45%
2019 FY	155.47 Million TWD	-5.05%
2019 Q1	42.53 Million TWD	7.52%
2019 Q4	36.07 Million TWD	-6.33%
2019 Q2	38.34 Million TWD	-9.86%
2018 Q3	42.53 Million TWD	-2.44%
2018 Q2	43.59 Million TWD	14.53%
2018 FY	163.75 Million TWD	-3.61%
2018 Q4	39.56 Million TWD	-6.98%
2018 Q1	38.06 Million TWD	-2.55%
2017 Q2	44.94 Million TWD	10.21%
2017 Q4	39.05 Million TWD	-13.4%
2017 Q1	40.77 Million TWD	13.53%
2017 FY	169.87 Million TWD	7.43%
2017 Q3	45.1 Million TWD	0.36%
2016 Q2	42.39 Million TWD	10.97%
2016 FY	158.13 Million TWD	-2.76%
2016 Q4	35.91 Million TWD	-13.69%
2016 Q3	41.61 Million TWD	-1.85%
2016 Q1	38.2 Million TWD	-6.63%
2015 FY	162.63 Million TWD	0.84%
2015 Q4	40.92 Million TWD	-3.17%
2015 Q2	40.07 Million TWD	1.8%
2015 Q3	42.26 Million TWD	5.44%
2015 Q1	39.37 Million TWD	-1.11%
2014 Q3	40.11 Million TWD	1.16%
2014 FY	161.27 Million TWD	2.78%
2014 Q4	39.81 Million TWD	-0.74%
2014 Q2	39.65 Million TWD	-4.91%
2014 Q1	41.69 Million TWD	7.74%
2013 Q3	38.31 Million TWD	-2.78%
2013 Q4	38.7 Million TWD	1.02%
2013 FY	156.92 Million TWD	-3.61%
2013 Q1	40.5 Million TWD	-5.3%
2013 Q2	39.4 Million TWD	-2.71%
2012 Q3	38.72 Million TWD	-1.2%
2012 FY	162.8 Million TWD	9.79%
2012 Q4	42.76 Million TWD	10.43%
2012 Q2	39.19 Million TWD	-4.16%
2012 Q1	40.89 Million TWD	11.4%
2011 Q3	35.94 Million TWD	-5.7%
2011 Q4	36.71 Million TWD	2.12%
2011 FY	148.28 Million TWD	-0.93%
2011 Q1	37.5 Million TWD	-3.28%
2011 Q2	38.12 Million TWD	1.65%
2010 Q1	35.5 Million TWD	0.0%
2010 FY	149.67 Million TWD	8.81%
2010 Q3	36.74 Million TWD	-4.97%
2010 Q4	38.77 Million TWD	5.54%
2010 Q2	38.66 Million TWD	8.91%
2009 FY	137.55 Million TWD	0.0%

Peer Operating Expenses Comparison of Abnova (Taiwan) Corporation

Name	Operating Expenses	Operating Expenses Difference
Apex Biotechnology Corp.	389.4 Million TWD	67.457%
Sinphar Pharmaceutical Co.,Ltd.	807.86 Million TWD	84.314%
Panion & Bf Biotech Inc.	817.56 Million TWD	84.5%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	437.58 Million TWD	71.041%
GenMont Biotech Incorporation	204.2 Million TWD	37.944%
Adimmune Corporation	1.13 Billion TWD	88.822%
Tanvex BioPharma, Inc.	2.16 Billion TWD	94.135%
Polaris Group	-3.06 Million TWD	4234.454%
Energenesis Biomedical CO.,LTD.	267.06 Million TWD	52.55%
UnicoCell Biomed Co., Ltd.	17.89 Million TWD	-608.057%
PELL Bio-Med Technology Co. Ltd.	385.1 Million TWD	67.095%

Global Stocks Search

Abnova (Taiwan) Corporation (4133.TW)

Operating Expenses Summary of Abnova (Taiwan) Corporation

Annual Operating Expenses Chart of Abnova (Taiwan) Corporation (2023 - 2009)

Historical Annual Operating Expenses of Abnova (Taiwan) Corporation (2023 - 2009)

Peer Operating Expenses Comparison of Abnova (Taiwan) Corporation